No Data
No Data
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Baird Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $200
Curbline Properties & TransMedics Group to Join S&P SmallCap 600; The Ensign Group Set to Join S&P MidCap 400
Trending Stocks Today | The Real Good Food Shoots up 64.89% Post-Market
TransMedics to Replace Ensign Group in S&P 600 at Open on 10/1
TransMedics Started at Outperform by Baird Over Transplant Technology
No Data
No Data